JP Morgan Upgrades Solid Biosciences to Overweight, Raises Price Target to $15
Portfolio Pulse from Benzinga Newsdesk
JP Morgan has upgraded Solid Biosciences (NASDAQ:SLDB) from Neutral to Overweight and raised the price target from $10 to $15.

July 15, 2024 | 12:04 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
JP Morgan analyst Anupam Rama has upgraded Solid Biosciences from Neutral to Overweight and increased the price target from $10 to $15.
The upgrade from Neutral to Overweight and the increase in price target from $10 to $15 by a reputable analyst at JP Morgan is likely to positively impact investor sentiment and drive the stock price higher in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100